Category: Research Roundtable

KIF1A.ORG’s 23rd Research Roundtable meeting, “Structure to Patient Perspective: Vision Loss in KAND” was presented by KIF1A.ORG’s Dr. Dylan Verden. Let’s learn more about why KIF1A may impact vision, and where we can look for potential therapeutic leads.

KIF1A.ORG’s 22nd Research Roundtable meeting, “High-resolution structures of microtubule-bound KIF1A and its pathogenic variant P305L” was presented by Dr. Henando Sosa from the Albert Einstein College of Medicine. Let’s learn more about why understanding KIF1A structure is so important, and how it can inform new therapeutics.

KIF1A.ORG’s 21st Research Roundtable meeting, “Beginning to map the interactome for KAND”, was presented by Ethan Beswick and Dr. Alok Tayi of Vibe Bio. Learn about how Vibe Bio is developing data tools to empower KAND research.

KIF1A.ORG’s 20th Research Roundtable meeting, “Investigation of Kif1a mouse models and therapeutic interventions,” was presented by Dr. Markus Terrey from The Jackson Laboratory (JAX). Read on to learn more about how JAX is creating animal models to better investigate and treat and KAND.

KIF1A.ORG’s 19th Research Roundtable meeting, “NeuCyte KAND disease modeling drug screening platform,” was presented by Dr. Wayne Poon from NeuCyte. Read on to learn more about how NeuCyte is developing new ways to test therapeutics for KAND.

KIF1A.ORG’s 18th Research Roundtable meeting, “The mechanochemistry of bidirectional axonal transport,” was presented by Dr. William Hancock from Pennsylvania State University. Read on to learn more about how the Hancock Lab is advancing our understanding of KIF1A function.

KIF1A.ORG’s 17th Research Roundtable meeting, “A new KAND barometer: The number of KIF1A molecules needed for axonal transport” was presented by Dr. Kumiko Hayashi at Tohoku University in Japan.

KIF1A.ORG’s 16th Research Roundtable meeting, “Disease-associated heterodimers are more toxic than homodimers” was presented by Dr. Shinsuke Niwa at Tohoku University in Japan.

KIF1A.ORG’s 15th Research Roundtable meeting, “2022 Goals/Updates from KIF1A.ORG + From structure to patient perspective: an exploration of common KIF1A variants – part 2 ” was presented by Dr. Dominique Lessard, Chief Science Officer of KIF1A.ORG.

KIF1A.ORG’s 14th Research Roundtable meeting, “Updates from KIF1A.ORG and Dr. Wendy Chung/Chung Lab” was presented by Dr. Wendy Chung, Dr. Lia Boyle, Dr. Michael Zuccaro, and Dr. Charles LeDuc of Columbia University. Read on to learn more about the progress the Chung Lab is making toward a better understanding of KAND and therapeutic development thanks…

KIF1A.ORG’s 13th Research Roundtable meeting, “Introduction to Treatment Accelerator Program and Presentation by NeuCyte,” was presented by Dr. Dominique Lessard, Chief Science Officer of KIF1A.ORG, and Dr. Ji Wu, Vice President of Business Development and Operations of NeuCyte.